- 全部删除
- 您的购物车当前为空
我们很想知道您的意见反馈,所以我们在每个页面上都梳理出一个反馈按钮。
RLX is a PI3K/Akt/FoxO3a signaling inhibitor in experimental colon cancer.
RLX is a PI3K/Akt/FoxO3a signaling inhibitor in experimental colon cancer.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 10,600 | In stock | |
50 mg | ¥ 13,800 | In stock | |
100 mg | ¥ 17,500 | In stock |
产品描述 | RLX is a PI3K/Akt/FoxO3a signaling inhibitor in experimental colon cancer. |
别名 | THA-Q, THA Q, PD-139530, PD139530, PD 139530 |
CAS No. | 4425-23-4 |
Smiles | O=C1N2CCCCCC2=NC2=C1C=CC=C2 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容